Juan David Cala-Garcia

6PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersLife historiesTissue engineeringMetabolic medicineMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 12, 2026
Early Pulmonary Fibrosis is Defined by Niche- and Cell-Specific Molecular Programs.

|Jan 22, 2026
Single-cell atlas of human lung aging identifies cell type dyssynchrony and increased transcriptional entropy.

Ruben De Man, John E McDonough, Taylor S Adams

|Aug 02, 2025
Inhibition of epithelial cell YAP-TEAD/LOX signaling attenuates pulmonary fibrosis in preclinical models.

Darcy Elizabeth Wagner, Hani N Alsafadi, Nilay Mitash

|Sep 28, 2023
The Role of Mitochondrial Dysfunction in Idiopathic Pulmonary Fibrosis: New Perspectives for a Challenging Disease.

Juan David Cala-Garcia, German Jose Medina-Rincon, Paula Andrea Sierra-Salas

|May 28, 2022
Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?

Daniela Baracaldo-Santamaría, Juan David Cala-Garcia, Germán José Medina-Rincón

|Jul 16, 2020
Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients.

Juan David Cala-García, Juan David Sierra-Bretón, Jorge Eduardo Cavelier-Baiz

Pageof 1

Frequent Collaborators

3 joint publications

Naftali Kaminski

2 joint publications

Cristian Coarfa

2 joint publications

Germán José Medina-Rincón

1 joint publications

Ruben De Man